Markets:

Overview

News

Currencies

International

Treasuries

AbbVie (NY:ABBV)

226.08 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

90 91 Next >

A Peek at AbbVie's Future Earnings ↗

July 30, 2025

Via Benzinga

Got $500? 3 Blue Chip Dividend Stocks to Buy and Hold Forever ↗

July 30, 2025

Being a great investor doesn't have to be complicated or expensive.

Via The Motley Fool

Topics Intellectual Property

AbbVie (ABBV) Reports Q2: Everything You Need To Know Ahead Of Earnings

July 29, 2025

Pharmaceutical company AbbVie (NYSE:ABBV) will be reporting earnings this Thursday before market open. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

Eli Lilly’s Cancer Drug Demonstrates Better Effectiveness Than AbbVie’s In Late Stage Trial: Retail Believes In Holding The Stock ↗

July 29, 2025

Jaypirca had an overall response rate better than AbbVie’s Imbruvica in the study, meaning a higher percentage of patients treated with Jaypirca experienced their cancer shrink or disappear after...

Via Stocktwits

Why Is ATAI Life Sciences Stock Trading Lower On Monday? ↗

July 28, 2025

Recognify's CIAS trial for inidascamine missed its main endpoint but showed positive signals in cognitive domains and had a favorable safety profile.

Via Benzinga

Looking Into AbbVie's Recent Short Interest ↗

July 16, 2025

Via Benzinga

2 Top Dividend Stocks to Buy Right Now and Hold Forever ↗

July 28, 2025

Long-term shareholders have already seen significant gains from these stocks, and there's likely much more to come for patient investors.

Via The Motley Fool

Topics Intellectual Property

3 Value Stocks with Questionable Fundamentals

July 28, 2025

Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few...

Via StockStory

The Smartest Dividend Stocks to Buy With $350 Right Now ↗

July 26, 2025

These stocks offer juicy dividends, solid growth prospects, and stability.

Via The Motley Fool

The 3 Things That Matter for AbbVie Now ↗

July 24, 2025

Via The Motley Fool

Topics Intellectual Property

Uber, Western Union, Live Nation Entertainment And A Health Care Stock On CNBC's 'Final Trades' ↗

July 24, 2025

Analysts and investors are closely watching earnings from AbbVie, Uber, and Western Union to gain insights on market trends. AbbVie expected to see breakout on July 31.

Via Benzinga

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields ↗

July 21, 2025

Via Benzinga

All It Takes Is $2,000 Invested in Each of These High Dividend Stocks to Help Generate Over $280 in Passive Income Per Year ↗

July 19, 2025

Via The Motley Fool

My Top 2 Earnings Picks For This Earnings Season ↗

July 16, 2025

Via Benzinga

July 14, 2025

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other...

Via StockStory

3 Dividend Growth Stocks to Buy and Hold ↗

July 12, 2025

Via The Motley Fool

Topics Intellectual Property

The Smartest Dividend Stocks to Buy With $300 Right Now ↗

July 12, 2025

Via The Motley Fool

Topics Energy Government World Trade

Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies ↗

July 11, 2025

Donald Trump's proposed 200% tariffs can squeeze the profit margins of pharma companies, but LLY is poised to "benefit" except for the rest.

Via Benzinga

Topics Government World Trade

Boeing, Joby Aviation, Oracle And A Health Care Stock: CNBC's 'Final Trades' ↗

July 11, 2025

The investment landscape is shifting as companies show resilience and innovation, prompting investors to reassess portfolios. AbbVie, Boeing, Oracle, and Joby Aviation mentioned as potential...

Via Benzinga

What Is Considered a Good Dividend Stock? 3 Healthcare Stocks That Fit the Bill ↗

July 11, 2025

A steady dose of quality companies will keep your portfolio growing big and strong.

Via The Motley Fool

Topics Intellectual Property

AbbVie Enters Licensing Agreement For IGI Therapeutics’ Experimental Oncology Drug: Retail Cheers ↗

July 10, 2025

Under the terms of the agreement, AbbVie will receive exclusive rights to develop, manufacture, and commercialize ISB 2001 across North America, Europe, Japan, and Greater China.

Via Stocktwits

Topics Product Recall

Why Is AbbVie Stock Trading Higher On Thursday? ↗

July 10, 2025

AbbVie licensed IGI's trispecific myeloma drug ISB 2001 in a deal worth up to $1.925 billion following strong early-phase clinical data.

Via Benzinga

Trump Threatens 200% Tariffs On Drug Imports, Says Big Pharma Will Get Some Time 'To Get Their Act Together' ↗

July 08, 2025

Pharmaceutical investors are being cautious, with concerns over potential supply disruptions, cost pressures, and uncertainty regarding policy implementation.

Via Stocktwits

Topics ETFs Economy Government

3 No-Brainer Stocks to Buy in July ↗

July 07, 2025

Via The Motley Fool

2 Dividend Stocks to Buy for Decades of Passive Income ↗

July 06, 2025

Via The Motley Fool

Topics Intellectual Property

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever ↗

July 05, 2025

Via The Motley Fool

Topics Economy Intellectual Property

AstraZeneca In $15B Talks For Drug That Could Upend Lung Cancer Treatment ↗

July 03, 2025

Via Benzinga

Novartis' Cosentyx Fails Late-Stage Giant Cell Arteritis Trial ↗

July 03, 2025

Cosentyx missed its main goal in a Phase 3 GCA study, but showed lower steroid use. Novartis plans full review of the trial data.

Via Benzinga

3 Profitable Stocks Skating on Thin Ice

July 03, 2025

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...

Via StockStory

July 01, 2025

Via The Motley Fool

Topics Artificial Intelligence ETFs Stocks

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

90 91 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Oil & Gas Journal starts where other industry publications stop. It delivers more than information; it delivers context, adding details the others leave out and combining them with analysis, commentary, industry trends, and statistics.

Newsletters

The top stories, industry insights and relevant research, assembled by our editors and delivered to your inbox.

Connect

http://www.facebook.com/ogjonline

https://www.linkedin.com/company/oil-&-gas-journal

http://twitter.com/ogjonline

Affiliated Brands

About Us
Advertise
Do Not Sell or Share
Privacy Policy
Terms & Conditions